- Home
- INCR
INCR
Intercure Ltd.
as 07-26-2024 4:00pm EST
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
| Founded: | 1994 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 119.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 29.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.99 - $3.72 | Next Earning Date: | 09-23-2024 |
| Revenue: | $97,948,485 | Revenue Growth: | -1.99% |
| Revenue Growth (this year): | -15.01% | Revenue Growth (next year): | 52.65% |
Latest Intercure Ltd. News
INCR Breaking Stock News: Dive into INCR Ticker-Specific Updates for Smart Investing
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
Simply Wall St.
2 months ago
OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
Barrons.com
2 months ago
Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
Simply Wall St.
2 months ago
Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
Simply Wall St.
2 months ago
An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
Compare INCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INCR Intercure Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.